Clinical Trials
27 trialsNCT02725424 2022-08-17
MATCH
ChineseAMS
Phase 2 Completed
NCT05499195 2022-08-12
Adjuvant Radiotherapy for pT1b Esophageal Cancer After Submucosal Endoscopic Resection
ChineseAMS
Completed
NCT04247984 2022-03-11
A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer
ChineseAMS
Phase 2 Completed
NCT05194371 2022-01-18
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
ChineseAMS
Completed
NCT02992886 2021-09-09
Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly
ChineseAMS
Phase 2 Completed
NCT01463605 2021-02-04
Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial
ChineseAMS
Phase 2 Completed
NCT03083613 2021-02-01
Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03415802 2021-02-01
Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic Cancer
ChineseAMS
Phase 2 Completed
NCT03443661 2021-02-01
Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer
ChineseAMS
Phase 2 Completed
NCT03830606 2021-02-01
The Efficacy and Safety of Nab-paclitaxel Plus S-1 in First-line Treatment of Advanced Biliary Tract Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT02979691 2020-07-21
Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01
ChineseAMS
Phase 2/3 Completed
NCT02301481 2019-10-16
A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT03298204 2019-01-02
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
ChineseAMS
Completed
NCT02295774 2018-11-05
Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
CosmoTech
Phase 2 Completed
NCT01694966 2017-11-06
The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
CosmoTech
Phase 3 Completed
NCT02446574 2017-10-24
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 1/2 Completed
NCT01456156 2017-07-05
Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma
ChineseAMS
Phase NA Completed
NCT02429622 2017-01-18
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
ChineseAMS
Phase 1/2 Completed
NCT02312284 2016-01-18
Observational Study on the Patients With Rectal Cancer
ChineseAMS
Completed
NCT01584544 2015-04-20
Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
ChineseAMS
Phase 1 Completed
NCT02133612 2015-04-14
Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma
ChineseAMS
Phase 2 Completed
NCT01268943 2015-04-06
Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients
ChineseAMS
Phase 1 Completed
NCT02370849 2015-02-25
Cisplatin and S-1 With or Without Nimotuzumab in Untreated Advanced Gastric Adenocarcinoma
ChineseAMS
Phase 2 Completed
NCT01531452 2014-12-04
The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer
ChineseAMS
Phase 2 Completed
NCT01444521 2014-05-06
Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
ChineseAMS
Phase 2 Completed
NCT02094105 2014-03-21
Endoscopic Screening on Esophageal Cancer
ChineseAMS
Phase NA Completed
NCT01291407 2013-09-18
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer
ChineseAMS
Phase 1 Completed